New blood test detects 90% of aggressive prostate cancer cases, beating current screenings

Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...
MedPage Today on MSN

Multicomponent Test Tops PSA for Clinically Significant Prostate Cancers

Blood-based biomarker test had similar false-positive rate as PSA, while reducing false ne ...
Medscape

PSA Screening May Modestly Curb Prostate Cancer Deaths, but With Caveats

New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress ...
Medical Xpress

Scientists get closer to a better PSA test

The most common screening test for prostate cancer so often returns a false positive result that it's no longer recommended for men older than 70, and it's offered as a personal choice for younger men ...
Nature

Understanding biochemical recurrence after radical prostatectomy: trust biology, not a number

In the current issue of Prostate Cancer Prostatic Diseases, Szymaniak and colleagues from UCSF present long term oncologic outcomes of patients who presented a non-detectable PSA after radical ...